2024 / 02

Next Paper
DOI: 10.24075/brsmu.2024.014

CLINICAL CASE

Multidisciplinary approach to treatment of unresectable liver metastases seeded by luminal breast carcinoma

Kolomiets KV, Afashagova ZR, Erendzhenova DE, Bashirova AS, Falchari VV, Babayeva NE, Aliyeva AD, Kurmalieva RZ, Fedoseyev YB
About authors

Rostov State Medical University, Rostov-on-Don, Russia

Correspondence should be addressed: Karina V. Kolomiets
Krasnoarmeyskaya st., 198, Novocherkassk, 346400, Russia; ur.liam@99_steimolok_anirak

About paper

Author contribution: Kolomiets KV — article authoring, editing; Afashagova ZR, Erendzhenova DE — literature review, article authoring, data analysis; Bashirova AS, Falchari VV — literature review, data collection, article authoring; Babayeva NE, Aliyeva AD — concept and design, literature review, article authoring; Kurmalieva RZ, Fedoseyev YuB — literature review, article authoring and editing.

Compliance with ethical standards: the patient signed a voluntary informed consent to publication of anonymized medical information.

Received: 2024-02-19 Accepted: 2024-04-18 Published online: 2024-04-29
|
  1. Bray F, Laversanne M, Sung H, et. al. Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 4. DOI: 10.3322/caac.21834.
  2. Loibl S, Poortmans P, Morrow M, et. al. Breast cancer. Lancet. 2021; 8; 397 (10286):1750–69. DOI: 10.1016/S0140-6736(20)32381-3.
  3. Liberchuk AN, Deipolyi AR. Hepatic Metastasis from Breast Cancer. Semin Intervent Radiol. 2020; 37 (5): 518–26; DOI: 10.1055/s-0040-1720949.
  4. Eng LG, Dawood S, Sopik V, et. al. Ten-year survival in women with primary stage IV breast cancer. Breast Cancer Res Treat. 2016; 160 (1): 145–52; DOI: 10.1007/s10549-016-3974-x.
  5. Cersosimo RJ. Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women. Am J Health Syst Pharm. 2019; 76 (16): 1183–202. DOI: 10.1093/ajhp/zxz121.
  6. Yardley DA, Chan A, Nusch A, et al. Abstract P6-18-07: Ribociclib+ endocrine therapy in patients with hormone receptor-positive, HER2-negative advanced breast cancer presenting with visceral metastases: Subgroup analysis of phase III MONALEESA trials. Canc Research. 2019; 79 (4): P6-18-07 — P6-18-07; DOI: 10.1158/1538-7445.SABCS18-P6-18-07.
  7. Barakat E, Bibok A, Rishi A, et al. Transarterial Yttrium-90 glass microsphere radioembolization of chemotherapy-refractory breast cancer liver metastases: results of a single institution retrospective study. Adv Radiat Oncol. 2021; 7 (1): 100838; DOI: 10.1016/j.adro.2021.100838.
  8. Wang L, Lin ZG, Ke Q, et. al. Adjuvant transarterial chemoembolization following radical resection for intrahepatic cholangiocarcinoma: A multi-center retrospective study. J Cancer. 2020; 11 (14): 4115–22; DOI:10.7150/jca.40358.
  9. Surveillance, Epidemiology, and End Results Program, Research Data (1975–2016), National Cancer Institute (NCI), Division of Cancer Control and Population Sciences (DCCPS), Surveillance Research Program (SRP), released April 2019. Available from: https://seer.cancer.gov/.